Qijia Xuan

1.2k citations
30 papers · 922 indexed · h-index 18
Topics
Cancer Immunotherapy and Biomarkers (7 papers)Cancer Cells and Metastasis (4 papers)Inflammatory Biomarkers in Disease Prognosis (4 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
Partner nations
ChinaJapan

In The Last Decade

Qijia Xuan

30 papers receiving 916 citations

Peers

Qijia Xuan
Comparison fields: 5 of 91
  • Oncology 511
  • Molecular Biology 325
  • Cancer Research 241
  • Immunology 223
  • Pulmonary and Respiratory Medicine 161
Replace Étienne Buscail with:
Étienne Buscail France
Yunpeng Peng China
Yozo Suzuki Japan
Vanja Vaccaro Italy
Hiroaki Kasashima Japan
Fuxiang Zhou China
Karim Rihawi Italy
Heinz‐Josef Lenz United States
Koichi Okamoto Japan
Takahiro Kogawa Japan
Qijia Xuan relative to Étienne Buscail France Étienne Buscail's profile →
Citations per field
00.5×1.5×2.1×
Étienne Buscail · 1×
Citations per year

Countries citing papers authored by Qijia Xuan

Since Specialization
Citations

This map shows the geographic impact of Qijia Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qijia Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qijia Xuan more than expected).

Fields of papers citing papers by Qijia Xuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qijia Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qijia Xuan. The network helps show where Qijia Xuan may publish in the future.

Co-authorship network of co-authors of Qijia Xuan

This figure shows the co-authorship network connecting the top 25 collaborators of Qijia Xuan. A scholar is included among the top collaborators of Qijia Xuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qijia Xuan. Qijia Xuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4
Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
5
5 7
6 39
7 22
8 23
9 30
10 3
11 79
12 62
13 14
14 117
15 50
16 7
17 24
18 17
19 14
20 66

About Qijia Xuan

Qijia Xuan is a scholar working on Oncology, Cancer Research and Family Practice, having authored 30 papers that have together received 922 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). The work is most often cited by research in Oncology (511 citations), Cancer Research (241 citations) and Immunology (223 citations). Qijia Xuan has collaborated with scholars based in China and Japan. Frequent co-authors include Qingyuan Zhang, Jingxuan Wang, Tieying Dong, Shu Zhao, Qingyuan Zhang, Zhipeng Wang, Wenjie Ma, Zhaoliang Liu, Xin Lian and Hang Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026